Anzu Special Acquisition Corp I (Nasdaq: ANZU) announced this afternoon that it has once again adjourned its special meeting, scheduled for today, until February 28.
The SPAC was holding today’s meeting to extend its completion deadline by six months from March 4 up to September 30.
Anzu’s previously scheduled extension votes were also adjourned. However, earlier this morning Anzu disclosed its intent to sign an agreement with an insurance agent to cover the 1% excise tax liability, thereby maintaining the redemption value at $10.17.
Anzu investors also have its $150 million LOI with Envoy Medical to consider, which requires the SPAC to have at least $40 million in its trust in order for the deal to close. The US-based medical device company has developed and is in early clinical testing of fully implanted cochlear implants.
Globa Terra Acquisition Corporation (NASDAQ:GTERU) announced the pricing of its $152 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “GTERU”, Wednesday, July 9, 2025. The new SPAC plans to mount a search for a target in the agriculture, agtech or biotech sectors with an emphasis on water...
M3-Brigade V (NASDAQ:MBAV) has entered into a definitive agreement to combine with crypto treasury firm ReserveOne, assembling about $1 billion in equity funding. ReserveOne is setting up a diversified Bitcoin and digital asset treasury with a portion of its investments going towards blockchain infrastructure and venture raises. The combined company is expected to trade on...
At the SPAC of Dawn As the SPAC market has warmed in 2025, only 21 of the 70 SPACs (30%) that have IPO’d thus far have overfunded their trusts to draw in investors and none of these funded to more than 101%. By contrast, 87% of 2023 SPACs were overfunded – some to as high...
Emmis Acquisition Corporation (NASDAQ:EMISU) has filed for a $100 million SPAC to take a look at the manufacturing sector after a few unique wrinkles in their IPO process. Initial investors are set to receive one right to a 1/10 share in each unit purchased and the SPAC will have 18 months to complete a business...
Chenghe III (NASDAQ:CHEC.U) has filed for a $110 million SPAC to continue the team’s growing series while turning to a new underwriter. The new SPAC is offering investors a 1/2 warrant in each unit and no overfunding of the trust, but it will need to complete a business combination within 18 months of its IPO...